1. Tang, Ze-Yi, Wang, Xiao-Min, Xu, Chun-Wei, Cheng, Shu-Qun, Pan, Wei-Wei. 2024. DCAF13 promotes ovarian cancer progression by activating FRAS1-mediated FAK signaling pathway. In Cellular and molecular life sciences : CMLS, 81, 421. doi:10.1007/s00018-024-05446-2. https://pubmed.ncbi.nlm.nih.gov/39367995/
2. Shan, Bao-Qian, Wang, Xiao-Min, Zheng, Li, Pan, Wei-Wei, Zhang, Xin. 2022. DCAF13 promotes breast cancer cell proliferation by ubiquitin inhibiting PERP expression. In Cancer science, 113, 1587-1600. doi:10.1111/cas.15300. https://pubmed.ncbi.nlm.nih.gov/35178836/
3. Manzoor, Humera, Zahid, Hafsa, Emerling, Christopher A, Wajid, Muhammad, Naz, Sadaf. 2023. A biallelic variant of DCAF13 implicated in a neuromuscular disorder in humans. In European journal of human genetics : EJHG, 31, 629-637. doi:10.1038/s41431-023-01319-7. https://pubmed.ncbi.nlm.nih.gov/36797467/
4. Zhang, Yin-Li, Zhao, Long-Wen, Zhang, Jue, Gao, Shaorong, Fan, Heng-Yu. 2018. DCAF13 promotes pluripotency by negatively regulating SUV39H1 stability during early embryonic development. In The EMBO journal, 37, . doi:10.15252/embj.201898981. https://pubmed.ncbi.nlm.nih.gov/30111536/
5. Ieranò, Caterina, Righelli, Dario, D'Alterio, Crescenzo, Melillo, Rosa Marina, Scala, Stefania. . In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2021-004032. https://pubmed.ncbi.nlm.nih.gov/35246475/
6. Zhang, Jue, Zhang, Yin-Li, Zhao, Long-Wen, Ou, Xiang-Hong, Fan, Heng-Yu. 2018. Mammalian nucleolar protein DCAF13 is essential for ovarian follicle maintenance and oocyte growth by mediating rRNA processing. In Cell death and differentiation, 26, 1251-1266. doi:10.1038/s41418-018-0203-7. https://pubmed.ncbi.nlm.nih.gov/30283081/
智鼠故事 
